Scott Webster Research Group

Information on the research interests, projects, and members of Scott Webster's Research Group.

Professor Scott Webster

Personal Chair of Medicines Discovery


The primary focus of my research is drug discovery. I conduct translational research with a focus on discovering and developing small molecules as drugs for the treatment of conditions such as Alzheimer’s disease, acute pancreatitis, liver fibrosis and multiple sclerosis. This is research is highly collaborative with close involvement of both academic and industrial collaborators across a range of discplines. My research has led to the discovery of a number of potent small molecule inhibitors of target enzymes, with the most advanced compound, UE2343 (XanamemTM), out-licensed and progressing through clinical trials in humans. My group provides expertise in target validation through assay devlopment and in vitro screening to lead optimisation and clinical candidate selection.

For a list of up-to-date publications, please visit:

Scott Webster's Profile Page

Research Group Members

Name(sorted in ascending order) Role Email
Andrew McBride Translational Projects Manager

Other Group Members

Pierre Rome Research Fellow